NEW YORK (Reuters Health) – A consensus statement compiled by an international panel proposes that the level of platelet reactivity during antiplatelet therapy is a better measure of…
NEW YORK (Reuters Health) – A new study of Ethiopian communities where azithromycin was distributed widely to prevent the spread of trachoma found that macrolide resistance dropped off…
NEW YORK (Reuters Health) – In high vascular risk patients, addition of clopidogrel to treatment with acetylsalicylic acid does not help minimize untoward events, researchers report in the…
NEW YORK (Reuters Health) – Despite numerous advances in treatment, evidence-based outpatient therapy for congestive heart failure (CHF) has not improved since 2002, researchers report in the August…
NEW YORK (Reuters Health) – Patients with an acute coronary syndrome referred for invasive treatment have similar outcomes whether they are given double-dose or standard-dose clopidogrel plus higher-dose…
NEW YORK (Reuters Health) – Patients with bipolar I disorder who haven’t been treated with a mood stabilizer and experience an episode of major depression may respond well…
NEW YORK (Reuters Health) – Rates of clearance of high-grade anal canal intraepithelial neoplasia in men with HIV are improved considerably by topical application of imiquimod cream, a…
NEW YORK (Reuters Health) – By lowering heart rate, the selective sinoatrial current inhibitor ivabradine improves outcomes in patients with chronic heart failure and an elevated heart rate,…
NEW YORK (Reuters Health) – Men undergoing androgen deprivation therapy for prostate cancer halve their risk of vertebral fractures if they take the selective estrogen receptor modulator toremifene…
NEW YORK (Reuters Health) – Patients undergoing percutaneous coronary intervention for acute coronary syndrome initially treated with the synthetic factor Xa inhibitor fondaparinux do not have significantly lower…